Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC
NCT03372694Phase 3Unknown
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Oct 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tunicamycin in non-small cell lung cancer (NSCLC), sponsored by Shanghai University of Traditional Chinese Medicine. Status: unknown.
02
Drugs
tunicamycin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03372694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372694.